CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
Jung Hyun Lee, Sung Gu Kang, Seung Tae Kim, Seok Ho Kang, In Keun Choi, Young Je Park, Sang Chul Oh, Deuk Jae Sung, Jae Hong Seo, Jun Cheon, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Kyong Hwa Park
Cancer Research and Treatment. 2014;46(2):172-177.   Published online 2014 April 15    DOI: https://doi.org/10.4143/crt.2014.46.2.172

Excel Download

Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
Cancer Research and Treatment. 2014;46(2):172-177   Crossref logo
Link1 Link2

Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
International Journal of Urology. 2007;14(11):1000-1004   Crossref logo
Link1 Link2

Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve
Bulletin du Cancer. 2020;107(5):eS1-eS7   Crossref logo
Link1 Link2

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)
BMC Cancer. 2015;15(1):   Crossref logo
Link1 Link2 Link3

Comparison of Clinical Outcomes in Patients With Localized or Locally Advanced Urothelial Carcinoma Treated With Neoadjuvant Chemotherapy Involving Gemcitabine-Cisplatin and High Dose-Intensity MVAC
. 2021;   Crossref logo
Link1 Link2

PCN185 - COST-EFFECTIVENESS OF NIVOLUMAB IN SECOND-LINE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA IN ADULTS AFTER FAILURE OF PRIOR PLATINUM-CONTAINING THERAPY IN GREECE
Value in Health. 2018;21:S46   Crossref logo
Link1 Link2

Ramucirumab as a Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: A Meta-Analysis of Randomized Clinical Trials
ECB 2021. 2021;   Crossref logo
Link1

P113 Design of an exploratory phase I study of pemetrexed in addition to vinflunine as second-line treatment in patients with metastatic urothelial cell carcinoma after prior treatment with platinum
European Urology Supplements. 2014;13(5):152-153   Crossref logo
Link1 Link2

Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study
Clinical Colorectal Cancer. 2007;6(9):646-651   Crossref logo
Link1 Link2

Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma
Journal of Urology. 2015;194(6):1583-1585   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.